Researchers at Purdue University have developed a technique using Doppler ultrasound, called biodynamic imaging (BDI), to predict chemoresistance in cancer patients. This method measures mechanical motions in cancer cells and how these change in response to chemotherapy, potentially identifying which patients will respond to treatment. Proven effective in both human and canine cancer trials, BDI offers a non-invasive way to tailor chemotherapy, improving personalized medicine. The technique is advancing from retrospective to prospective Phase II trials to predict patient responses before chemotherapy begins.
0
